United Therapeutics (UTHR) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to $2.1 billion.
- United Therapeutics' Other Gross PP&E Adjustments rose 2891.01% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 2891.01%. This contributed to the annual value of $1.7 billion for FY2024, which is 1628.66% up from last year.
- Latest data reveals that United Therapeutics reported Other Gross PP&E Adjustments of $2.1 billion as of Q3 2025, which was up 2891.01% from $1.9 billion recorded in Q2 2025.
- United Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $2.1 billion during Q3 2025, with a 5-year trough of $1.0 billion in Q1 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $1.3 billion (2023), whereas its average is $1.4 billion.
- Per our database at Business Quant, United Therapeutics' Other Gross PP&E Adjustments skyrocketed by 791.62% in 2021 and then surged by 2891.01% in 2025.
- United Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $1.1 billion in 2021, then rose by 10.76% to $1.2 billion in 2022, then grew by 18.44% to $1.5 billion in 2023, then rose by 16.29% to $1.7 billion in 2024, then increased by 22.79% to $2.1 billion in 2025.
- Its Other Gross PP&E Adjustments was $2.1 billion in Q3 2025, compared to $1.9 billion in Q2 2025 and $1.8 billion in Q1 2025.